Choi Young-Eun, Kim Chul-Woung
Clinical Research Coordinating Team, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
Department of Korean Medicine, The Graduate School, Pusan National University, Pusan 50612, Korea.
Healthcare (Basel). 2022 Sep 5;10(9):1697. doi: 10.3390/healthcare10091697.
This study was conducted using data from the Korea Medical Panel Survey (KMPS) carried out in 2015. Importantly, the purpose of this study was to investigate the relationship between Korean medicine (KM) and Western medicine (WM) in medical service use. The general characteristics and the frequency of utilization of medical services were analyzed for 18,130 participants. Chi-square analysis was used to examine the factors that affected medical service use. Additionally, logistic regression analysis was conducted to examine the odds ratio (OR) between the KM Use with WM Use and KM&WM Use with disease group. The proportion of respondents who used KM&WM was the highest among those over 65 years of age and it was found to be statistically significant (p < 0.001). The OR for using KM and WM was 3.236 and it was also statistically significant (p < 0.001). Further, the ORs of KM&WM Use for all seven disease groups were greater than 1 and were statistically significant (p < 0.001) except for respiratory disease. The significant ORs of KM&WM Use were 10.342 (musculoskeletal), 2.073 (exogenous causes), 1.988 (nervous), 1.677 (digestive), 1.541 (circulatory) and 1.386 (skin). The findings in this study were attributed to a combination of social aspects such as the increasing incidence of chronic diseases among the elderly population, policy aspects such as the collaborative pilot project to promote collaborative treatment (CT), economic aspects, such as a lower total cost for CT and scientific aspects such as evidence supporting the efficacy of CT.
本研究使用了2015年韩国医学面板调查（KMPS）的数据。重要的是，本研究的目的是调查韩医学（KM）与西医学（WM）在医疗服务使用方面的关系。对18130名参与者的一般特征和医疗服务使用频率进行了分析。采用卡方分析来检验影响医疗服务使用的因素。此外，进行逻辑回归分析以检验韩医学使用与西医学使用以及韩医学与西医学联合使用与疾病组之间的比值比（OR）。在65岁以上人群中，使用韩医学与西医学联合治疗的受访者比例最高，且具有统计学意义（p < 0.001）。使用韩医学和西医学的OR为3.236，也具有统计学意义（p < 0.001）。此外，除呼吸系统疾病外，所有七个疾病组的韩医学与西医学联合使用的OR均大于1且具有统计学意义（p < 0.001）。韩医学与西医学联合使用的显著OR分别为10.342（肌肉骨骼疾病）、2.073（外部原因）、1.988（神经系统疾病）、1.677（消化系统疾病）、1.541（循环系统疾病）和1.386（皮肤疾病）。本研究的结果归因于多种因素的综合作用，包括社会方面（如老年人群慢性病发病率上升）、政策方面（如促进联合治疗（CT）的合作试点项目）、经济方面（如CT的总成本较低）以及科学方面（如支持CT疗效的证据）。
